Skip to main content
Premium Trial:

Request an Annual Quote

New Cell-Based Screening Company Launches in Pittsburgh

NEW YORK, June 15 (GenomeWeb News) - Lansing Taylor, co-founder of Cellomics and the Pittsburgh Life Sciences Greenhouse, has founded a new company, Cellumen, the company said yesterday in its maiden announcement.


Cellumen, will initially will be headquarted at the PLSG's incubator and will form drug discovery collaborations with pharmaceutical and biotechnology companies using High-Content Screening, a cell-based screening method developed by Cellomics.


Taylor joined with Alan Waggoner from Carnegie Mellon University, who has had a hand in creating other life sciences technologies with Taylor. Taylor and Kenneth Giuliano, a scientist, will be Cellumen's first two employees. The company expects to have a total staff of five to six employees by the end of its first year of operation.


The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.